Tycel Phillips, MD, on Glofitamab Research, Progress in Mantle Cell Lymphoma

By Tycel Phillips, MD, Leah Sherwood - Last Updated: January 25, 2023

Tycel Phillips, MD, of the City of Hope, discusses a study of glofitamab, a bispecific antibody, in patients with relapsed/refractory mantle cell lymphoma (MCL). Dr. Phillips also shares his thoughts on the next steps for glofitamab research in patients with MCL, the future of bispecific antibody treatments, and more.

Advertisement
Editorial Board

Advertisement